Actively Recruiting

Phase 1
Phase 2
Age: 65Years +
All Genders
NCT07122908

The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies

Led by Korea University Anam Hospital · Updated on 2025-08-14

10

Participants Needed

1

Research Sites

137 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aimed to investigate the feasibility of repetitive transcranial magnetic stimulation (rTMS) on the occipital lobe in patients with Lewy body dementia. This is a proof-of-concept study to evaluate the safety and effect of occipital lobe stimulation in patients with Lewy body dementia. Over a period of two weeks, participants will receive rTMS to the primary visual cortex three times a week during visits. For the remaining 10 weeks, maintenance therapy will be administered with rTMS once a week during visits. Efficacy assessments will be conducted on the day of the final stimulation session and again four weeks later.

CONDITIONS

Official Title

The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 65 years of age
  • Meet the criteria for probable dementia with Lewy bodies based on the 2017 diagnostic guidelines
  • Clinical Dementia Rating (CDR) score between 0.5 and 1.0
Not Eligible

You will not qualify if you...

  • Suspected other causes of cognitive impairment such as neurosyphilis, thyroid disorders, metabolic encephalopathy, brain tumors, acute strokes, Wernicke's encephalopathy, or severe white matter changes
  • Difficulty cooperating with interviews or self-assessments due to hearing impairment, language disorders, or severe psychotic conditions
  • History of major psychiatric disorders including major affective disorder, schizophrenia, or schizo-affective disorder
  • Inability to undergo electroencephalography (EEG)
  • Presence of epileptiform EEG findings or current use of antiepileptic drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Korea University Anam Hospital

Seoul, Seoul, South Korea, 02841

Actively Recruiting

Loading map...

Research Team

K

Kyoungwon Baik, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here